120 related articles for article (PubMed ID: 28374160)
1. A case of contralateral breast cancer and skin cancer associated with NBN heterozygous pathogenic variant c.698_701delAACA.
Gass J; Jackson J; Macklin S; Blackburn P; Hines S; Atwal PS
Fam Cancer; 2017 Oct; 16(4):551-553. PubMed ID: 28374160
[TBL] [Abstract][Full Text] [Related]
2. Detecting Variants in the NBN Gene While Testing for Hereditary Breast Cancer: What to Do Next?
Zuntini R; Bonora E; Pradella LM; Amato LB; Vidone M; De Fanti S; Catucci I; Cortesi L; Medici V; Ferrari S; Gasparre G; Peterlongo P; Sazzini M; Turchetti D
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072463
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel NBN truncating mutation in a family with hereditary prostate cancer.
Zuhlke KA; Johnson AM; Okoth LA; Stoffel EM; Robbins CM; Tembe WA; Salinas CA; Zheng SL; Xu J; Carpten JD; Lange EM; Isaacs WB; Cooney KA
Fam Cancer; 2012 Dec; 11(4):595-600. PubMed ID: 22864661
[TBL] [Abstract][Full Text] [Related]
4. Identification of a rare germline NBN gene mutation by whole exome sequencing in a lung-cancer survivor from a large family with various types of cancer.
Marafie MJ; Dashti M; Al-Mulla F
Fam Cancer; 2017 Jul; 16(3):389-394. PubMed ID: 27844240
[TBL] [Abstract][Full Text] [Related]
5. Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer.
Desjardins S; Beauparlant JC; Labrie Y; Ouellette G; Durocher F;
BMC Cancer; 2009 Jun; 9():181. PubMed ID: 19523210
[TBL] [Abstract][Full Text] [Related]
6. Allelic modification of breast cancer risk in women with an NBN mutation.
Rusak B; Kluźniak W; Wokołorczyk D; Stempa K; Kashyap A; Rudnicka H; Gronwald J; Huzarski T; Dębniak T; Jakubowska A; Szwiec M; Akbari MR; Narod SA; Lubiński J; Cybulski C;
Breast Cancer Res Treat; 2019 Nov; 178(2):427-431. PubMed ID: 31410679
[TBL] [Abstract][Full Text] [Related]
7. Heterozygous germ-line mutations in the NBN gene predispose to medulloblastoma in pediatric patients.
Ciara E; Piekutowska-Abramczuk D; Popowska E; Grajkowska W; Barszcz S; Perek D; Dembowska-Bagińska B; Perek-Polnik M; Kowalewska E; Czajńska A; Syczewska M; Czornak K; Krajewska-Walasek M; Roszkowski M; Chrzanowska KH
Acta Neuropathol; 2010 Mar; 119(3):325-34. PubMed ID: 19908051
[TBL] [Abstract][Full Text] [Related]
8. Heterozygous mutations in the PALB2 hereditary breast cancer predisposition gene impact on the three-dimensional nuclear organization of patient-derived cell lines.
Wark L; Novak D; Sabbaghian N; Amrein L; Jangamreddy JR; Cheang M; Pouchet C; Aloyz R; Foulkes WD; Mai S; Tischkowitz M
Genes Chromosomes Cancer; 2013 May; 52(5):480-94. PubMed ID: 23341105
[TBL] [Abstract][Full Text] [Related]
9. Cancer risk of heterozygotes with the NBN founder mutation.
Seemanová E; Jarolim P; Seeman P; Varon R; Digweed M; Swift M; Sperling K
J Natl Cancer Inst; 2007 Dec; 99(24):1875-80. PubMed ID: 18073374
[TBL] [Abstract][Full Text] [Related]
10. The BARD1 Cys557Ser variant and breast cancer risk in Iceland.
Stacey SN; Sulem P; Johannsson OT; Helgason A; Gudmundsson J; Kostic JP; Kristjansson K; Jonsdottir T; Sigurdsson H; Hrafnkelsson J; Johannsson J; Sveinsson T; Myrdal G; Grimsson HN; Bergthorsson JT; Amundadottir LT; Gulcher JR; Thorsteinsdottir U; Kong A; Stefansson K
PLoS Med; 2006 Jul; 3(7):e217. PubMed ID: 16768547
[TBL] [Abstract][Full Text] [Related]
11. Nbn heterozygosity renders mice susceptible to tumor formation and ionizing radiation-induced tumorigenesis.
Dumon-Jones V; Frappart PO; Tong WM; Sajithlal G; Hulla W; Schmid G; Herceg Z; Digweed M; Wang ZQ
Cancer Res; 2003 Nov; 63(21):7263-9. PubMed ID: 14612522
[TBL] [Abstract][Full Text] [Related]
12. Functional deficiency of NBN, the Nijmegen breakage syndrome protein, in a p.R215W mutant breast cancer cell line.
Schröder-Heurich B; Bogdanova N; Wieland B; Xie X; Noskowicz M; Park-Simon TW; Hillemanns P; Christiansen H; Dörk T
BMC Cancer; 2014 Jun; 14():434. PubMed ID: 24928521
[TBL] [Abstract][Full Text] [Related]
13. NBN Gene Analysis and it's Impact on Breast Cancer.
Nithya P; ChandraSekar A
J Med Syst; 2019 Jul; 43(8):270. PubMed ID: 31278556
[TBL] [Abstract][Full Text] [Related]
14. Histopathological features of breast cancer in carriers of ATM gene variants.
Balleine RL; Murali R; Bilous AM; Farshid G; Waring P; Provan P; Byth K; Thorne H; ; Kirk JA
Histopathology; 2006 Nov; 49(5):523-32. PubMed ID: 17064299
[TBL] [Abstract][Full Text] [Related]
15. The c.657del5 variant in the NBN gene predisposes to pancreatic cancer.
Borecka M; Zemankova P; Lhota F; Soukupova J; Kleiblova P; Vocka M; Soucek P; Ticha I; Kleibl Z; Janatova M
Gene; 2016 Aug; 587(2):169-72. PubMed ID: 27150568
[TBL] [Abstract][Full Text] [Related]
16. Association of the nibrin gene (
Uzunoglu H; Korak T; Ergul E; Uren N; Sazci A; Utkan NZ; Kargi E; Triyaki Ç; Yirmibesoglu O
Biomed Rep; 2016 Mar; 4(3):369-373. PubMed ID: 26998278
[TBL] [Abstract][Full Text] [Related]
17. Familial male breast cancer.
Hauser AR; Lerner IJ; King RA
Am J Med Genet; 1992 Dec; 44(6):839-40. PubMed ID: 1336306
[No Abstract] [Full Text] [Related]
18. Heterozygous p.I171V mutation of the
Kałużna EM; Rembowska J; Ziółkowska-Suchanek I; Świątek-Kościelna B; Gabryel P; Dyszkiewicz W; Nowak JS
Oncol Lett; 2015 Nov; 10(5):3300-3304. PubMed ID: 26722329
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
[TBL] [Abstract][Full Text] [Related]
20. Clinical variability and expression of the NBN c.657del5 allele in Nijmegen Breakage Syndrome.
Lins S; Kim R; Krüger L; Chrzanowska KH; Seemanova E; Digweed M
Gene; 2009 Nov; 447(1):12-7. PubMed ID: 19635536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
